Painting the whole picture behind a vaccine shortage
As we look forward to hosting the Geneva Pharma Forum during current World Immunization Week, finding solutions to pre-empt or mitigate vaccine shortages is top-of-mind here at IFPMA and for our members. What’s more, recently the first Access to Vaccines Index (ATVI) was published – a set of report cards rich in data, and painting...
Read moreIFPMA statement at the close of the 3rd Fair Pricing Forum 13 to 22 April 2021
We thank the organizers, World Health Organization and Ministry of Health of Argentina for convening this meeting and for inviting representatives from the innovative biopharmaceutical industry to share our experience and perspectives on how we can work collectively toward improved access to medicines worldwide. It is with this mindset that we engaged in a constructive...
Read moreNew Non-State Actors Alliance calls on behalf of patients, industry for urgent action to set up the African Medicines Agency by the end of 2021
22 June – Paris/Geneva/London – Ministers of Health from four African countries (Algeria, Democratic Republic of Congo, Egypt and Cabo Verde), representatives from international organizations, patient groups and the pharmaceutical industry reiterated today at a high-level roundtable event the urgency of establishing a regulatory authority across Africa, especially in the context of the COVID-19 pandemic....
Read morePress Release: 3rd Biennial Scientific Conference on Medical Products Regulation in Africa
*3rd Biennial Scientific Conference on Medical Products Regulation in Africa* PRESS RELEASE, 27 November 2017, Accra – Ghana Significant strides have been made over the years to enhance and modernize the regulation of pharmaceutical manufacturing and product quality across the world. However, the drug registration system in Africa remains complex and varied, and separate...
Read moreGlobal biopharmaceutical industry sees upcoming World Health Assembly as a critical milestone to take stock of progress achieved and discuss enablers for future pandemic preparedness
The 74th World Health Assembly, taking place in extraordinary circumstances, represents a critical milestone in analyzing the world’s response to the COVID-19 pandemic. Member States will engage in conversations on improving current systems for pandemic surveillance and response, against the backdrop of having multiple effective, safe and quality COVID-19 vaccines available. Since the last World...
Read moreTechnical briefing on Biopharmaceutical Innovation: The Value of Legal Certainty
Read moreTechnical Briefing on Biodiversity
Read moreTechnical Briefing: Making Natural Product Research Work
Read moreTechnical Briefing on Biodiversity: Lilly recent history in natural products research, part 2
by Dr. Patrizia Carlevaro, Head of International Aid Unit, Eli Lilly and Company, Geneva IFPMA Geneva Pharma Forum on 24 November 2009
Read moreTechnical Briefing on Biodiversity: Lilly recent history in natural products research, part 1
by Dr. Patrizia Carlevaro, Head of International Aid Unit, Eli Lilly and Company, Geneva IFPMA Geneva Pharma Forum on 24 November 2009
Read more